BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36202977)

  • 1. Identidication of novel biomarkers in non-small cell lung cancer using machine learning.
    Wang F; Su Q; Li C
    Sci Rep; 2022 Oct; 12(1):16693. PubMed ID: 36202977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying lncRNAs and mRNAs related to survival of NSCLC based on bioinformatic analysis and machine learning.
    Yue W; Wang J; Lin B; Fu Y
    Aging (Albany NY); 2024 May; 16(9):7799-7817. PubMed ID: 38696317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune infiltration patterns and identification of new diagnostic biomarkers GDF10, NCKAP5, and RTKN2 in non-small cell lung cancer.
    Chen K; Ye C; Gao Z; Hu J; Chen C; Xiao R; Lu F; Wei K
    Transl Oncol; 2023 Mar; 29():101618. PubMed ID: 36628881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Prognosis of Non-small Cell Lung Cancer based on Machine Learning Algorithms.
    Zhou Y; Dong Y; Sun Q; Fang C
    Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
    Song J; Liang K; Wei T; Li L; Huang Z; Chen G; Mao N; Yang J
    Comb Chem High Throughput Screen; 2023; 26(12):2226-2237. PubMed ID: 36752296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
    Zhang JJ; Hong J; Ma YS; Shi Y; Zhang DD; Yang XL; Jia CY; Yin YZ; Jiang GX; Fu D; Yu F
    Dis Markers; 2021; 2021():6696198. PubMed ID: 33505535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration.
    Chen H; Lin C; Xue HM; Chen C; Yang M
    Thromb Res; 2023 Mar; 223():131-138. PubMed ID: 36746103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer.
    Dai B; Ren LQ; Han XY; Liu DJ
    J Int Med Res; 2020 Mar; 48(3):300060519887637. PubMed ID: 31775549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U.
    Pan J; Tang Y; Liu S; Li L; Yu B; Lu Y; Wang Y
    Cancer Med; 2020 Jun; 9(11):3829-3839. PubMed ID: 32239804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 12. TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhou F; Wang M; Aibaidula M; Zhang Z; Aihemaiti A; Aili R; Chen H; Dong S; Wei W; Maimaitiaili A
    Med Sci Monit; 2020 Aug; 26():e925147. PubMed ID: 32748897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hemoglobin alpha and hemoglobin beta in non-small-cell lung cancer based on bioinformatics analysis.
    Kang N; Qiu WJ; Wang B; Tang DF; Shen XY
    Mol Carcinog; 2022 Jun; 61(6):587-602. PubMed ID: 35394695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALAT1-regulated gene expression profiling in lung cancer cell lines.
    Roh J; Kim B; Im M; Jang W; Chae Y; Kang J; Youn B; Kim W
    BMC Cancer; 2023 Sep; 23(1):818. PubMed ID: 37667226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DTL as Related Biomarker and Immune Infiltration Characteristics of Nasopharyngeal Carcinoma via Comprehensive Strategies.
    Wang H; Zhang J
    Int J Gen Med; 2022; 15():2329-2345. PubMed ID: 35264872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
    Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
    Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.